Leukocyte telomere length decreased the risk of mortality in patients with alcohol-associated liver disease

被引:0
|
作者
Yi, Jiahong [1 ]
Guo, Hui [2 ]
Jiang, Chang [1 ]
Duan, Junyi [3 ]
Xue, Ju [1 ]
Zhao, Yue [1 ]
He, Wenzhuo [1 ]
Xia, Liangping [1 ]
机构
[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Prov Clin Res Ctr Canc, Canc Ctr,Dept VIP Reg,State Key Lab Oncol South Ch, Guangzhou, Peoples R China
[2] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, Guangdong Prov Clin Res Ctr Canc, Canc Ctr,State Key Lab Oncol South China, Guangzhou, Peoples R China
[3] Jinan Univ, Zhuhai Peoples Hosp, Zhuhai Hosp, Dept Obstet & Gynecol, Zhuhai, Peoples R China
来源
关键词
alcohol-associated liver disease; all-cause mortality; leukocyte telomere length; NHANES; prognosis; SENESCENCE; HEPATITIS; PATHOGENESIS; FIBROSIS;
D O I
10.3389/fendo.2024.1462591
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: It is necessary to find latent indicators to predict the survival of alcohol-associated liver disease (ALD) patients. Leukocyte telomere length (LTL) was regarded as an indicator of prognosis in several diseases. However, the relationships between LTL and survival as well as cause-specific mortality in ALD patients were still unknown. Objective: This study aimed at exploring the underlying link between LTL and the risk of mortality in patients with ALD. Methods: The LTL and survival data were gathered from the National Health and Nutrition Examination Survey (NHANES) 1999-2002. The connection between LTL and mortality was assessed by Cox regression models and stratified analyses. The non-linear relationship was explored by restricted cubic spline (RCS) analysis. Sensitivity analyses were used to evaluate the robustness of our findings. Results: LTL was a negative factor for all-cause mortality (all p-value < 0.05). The risk of cardiovascular disease (CVD)-related death was decreased in Q3 (p < 0.001) and Q4 levels of LTL (p < 0.001) compared with the Q1 group. Shorter LTL resulted in higher cancer-caused mortality (p = 0.03) in the Q2 group. Longer LTL improved survival especially for elder patients (p for trend < 0.001) or men (p for trend = 0.001). Moreover, there were L-shaped correlations between LTL and all-cause mortality (p for non-linearity = 0.02), as well as cancer-related mortality (p for non-linearity < 0.001). Four sensitivity analyses proved the robustness of our findings. Conclusion: Our research found that longer LTL improved survival in patients with ALD and decreased CVD and cancer-related mortality. LTL decreased all-cause mortality especially for patients older than 65 years or men. LTL might be a useful biomarker for prognosis among patients with ALD. More prospective studies are needed to assess the relevance between LTL and mortality and explore the underlying mechanisms between them.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Is the Leukocyte Telomere Length Associated with Decreased Physical Functional Capacity in the Elderly?
    Maximo Pereira, Fabiana Souza
    Thomasini, Ronaldo Luis
    Lustosa, Lygia Paccini
    Pereira, Daniele Sirineu
    Maximo Pereira, Leani Souza
    Issa Kassab, Gabriel Brum
    Silva, Thyago Jose
    Guerra, Ricardo Oliveira
    Parentoni, Adriana Netto
    REJUVENATION RESEARCH, 2020, 23 (05) : 387 - 393
  • [32] Noninvasive Tests in Assessment of Patients with Alcohol-Associated Liver Disease
    Sanchez, Lukas Otero
    Moreno, Christophe
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 715 - 729
  • [33] Alcohol consumption and leukocyte telomere length
    Dixit, Shalini
    Whooley, Mary A.
    Vittinghoff, Eric
    Roberts, Jason D.
    Heckbert, Susan R.
    Fitzpatrick, Annette L.
    Lin, Jue
    Leung, Cindy
    Mukamal, Kenneth J.
    Marcus, Gregory M.
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [34] Alcohol consumption and leukocyte telomere length
    Shalini Dixit
    Mary A. Whooley
    Eric Vittinghoff
    Jason D. Roberts
    Susan R. Heckbert
    Annette L. Fitzpatrick
    Jue Lin
    Cindy Leung
    Kenneth J. Mukamal
    Gregory M. Marcus
    Scientific Reports, 9
  • [35] Psychotherapy for Alcohol Use Disorder Is Associated With Reduced Risk of Incident Alcohol-Associated Liver Disease
    Vannier, Augustin G. L.
    Przybyszewski, Eric M.
    Shay, Jessica
    Patel, Suraj J.
    Schaefer, Esperance
    Goodman, Russell P.
    Luther, Jay
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2023, 21 (06) : 1571 - 1580
  • [36] Outcomes following liver transplant for alcohol-associated liver disease: comparing alcohol-associated hepatitis and cirrhosis
    Schroeder, Matthew
    Pedersen, Mark
    Petrasek, Jan
    Grant, Lafaine
    HEPATOLOGY COMMUNICATIONS, 2023, 7 (05)
  • [37] Alcohol Use Disorder and Alcohol-Associated Liver Disease
    Ramkissoon, Resham
    Shah, Vijay H.
    ALCOHOL RESEARCH-CURRENT REVIEWS, 2022, 42 (01):
  • [38] Barriers to Alcohol Use Disorder Treatment in Patients with Alcohol-Associated Liver Disease
    Leko, Andras H.
    Leggio, Lorenzo
    CLINICS IN LIVER DISEASE, 2024, 28 (04) : 779 - 791
  • [39] Leukocyte telomere length in subjects with metabolic dysfunction-associated steatotic liver disease
    Silva, Debora Goncalves da
    Silva, Nadyellem Graciano da
    Amato, Angelica Amorim
    ARAB JOURNAL OF GASTROENTEROLOGY, 2024, 25 (03) : 293 - 298
  • [40] Combination of Non-Selective Beta Blockers and Statins Is Associated With Decreased 90-Day Mortality in Alcohol-Associated Liver Disease
    Hossein-Javaheri, Nariman
    Podger, Blake
    Singh, Ikjot
    Gohil, Himaben
    Abulawi, Ahmad
    Martinez, Anthony
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2024, 119 (10S): : S1319 - S1319